Sonya S Patel, DO
Neurology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 5 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
26 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Patel’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$47,528
Medicare paid this office $47,528 for 189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 69 | $12,312 | $150 |
| New patient visit (60+ min) | 55 | $11,267 | $205 |
| Critical care, first 30-74 minutes | 15 | $5,904 | $185 |
| Return visit (30+ min) | 35 | $4,382 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,341 | $106 |
See all 8 services
| Long return visit (40+ min) | 69 | $12,312 | $150 |
| New patient visit (60+ min) | 55 | $11,267 | $205 |
| Critical care, first 30-74 minutes | 15 | $5,904 | $185 |
| Return visit (30+ min) | 35 | $4,382 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,341 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,985 | $153 |
| Emergency department visit with high level of medical decision making | 14 | $2,222 | $148 |
| Short return visit (20+ min) | 20 | $1,668 | $79 |
Who their Medicare patients are
189 Original Medicare patients in 2024. Average age 80 · 85 and older 30% · Women 59% · Also on Medicaid 9% · Health risk score 1.45. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 46% · Coronary heart disease 36% · Diabetes 34% · Atrial fibrillation 31% · Dementia 26% · Heart failure 23% · Depression 23% · Chronic kidney disease 22% · Cancer 16% · COPD 14%.
The office billed $77,985, Medicare allowed $63,032 and paid $47,528; for 326 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 189 | 326 | 80 | 1.45 | $77,985 | $47,528 |
| 2023 | 194 | 357 | 79 | 1.36 | $82,545 | $51,427 |
| 2022 | 174 | 351 | 79 | 1.38 | $82,930 | $52,617 |
| 2021 | 167 | 297 | 80 | 1.27 | $68,595 | $45,011 |
| 2020 | 174 | 309 | 79 | 1.39 | $66,875 | $37,164 |
| 2019 | 255 | 530 | 76 | 1.43 | $119,310 | $68,859 |
| 2018 | 234 | 454 | 77 | 1.35 | $103,690 | $59,475 |
| 2017 | 213 | 435 | 78 | 1.57 | $94,626 | $54,281 |
| 2016 | 156 | 325 | 77 | 1.43 | $70,915 | $42,321 |
| 2015 | 160 | 316 | 78 | 1.55 | $63,440 | $37,579 |
| 2014 | 127 | 223 | 78 | 1.41 | $44,625 | $26,951 |
| 2013 | 134 | 252 | 77 | 1.39 | $53,255 | $31,677 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 68 | $12,217 | $155 |
| New patient visit (60+ min) | 51 | $9,429 | $185 |
| Critical care, first 30-74 minutes | 15 | $7,894 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,417 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,144 | $106 |
| Return visit (30+ min) | 33 | $4,408 | $116 |
| New patient visit (45+ min) | 13 | $1,798 | $138 |
| Short return visit (20+ min) | 16 | $1,391 | $82 |
2022: 5 services
| Long return visit (40+ min) | 76 | $16,544 | $149 |
| New patient visit (60+ min) | 75 | $14,556 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $5,723 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,928 | $179 |
| Return visit (30+ min) | 27 | $3,231 | $111 |
2021: 6 services
| Long return visit (40+ min) | 72 | $14,647 | $153 |
| New patient visit (60+ min) | 71 | $13,944 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,789 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,306 | $94 |
| Return visit (30+ min) | 22 | $2,197 | $96 |
| Short return visit (20+ min) | 11 | $631 | $57 |
2020: 7 services
| Long return visit (40+ min) | 62 | $8,297 | $102 |
| New patient visit (60+ min) | 52 | $8,065 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,298 | $185 |
| Critical care, first 30-74 minutes | 13 | $5,398 | $200 |
| Return visit (30+ min) | 47 | $4,003 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,206 | $96 |
| Short return visit (20+ min) | 16 | $803 | $45 |
2019: 7 services
| Long return visit (40+ min) | 108 | $20,194 | $120 |
| New patient visit (60+ min) | 82 | $13,505 | $165 |
| Critical care, first 30-74 minutes | 22 | $9,555 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $8,657 | $89 |
| Emergency department visit with high level of medical decision making | 50 | $7,125 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,251 | $174 |
| Return visit (30+ min) | 24 | $2,428 | $90 |
2018: 7 services
| New patient visit (60+ min) | 93 | $15,521 | $167 |
| Long return visit (40+ min) | 73 | $14,020 | $120 |
| Critical care, first 30-74 minutes | 17 | $8,300 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,431 | $88 |
| Emergency department visit with high level of medical decision making | 41 | $5,806 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,790 | $170 |
| Return visit (30+ min) | 24 | $2,606 | $87 |
2017: 7 services
| New patient visit (60+ min) | 86 | $14,225 | $165 |
| Long return visit (40+ min) | 59 | $11,965 | $118 |
| Critical care, first 30-74 minutes | 22 | $8,043 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $6,704 | $85 |
| Emergency department visit with high level of medical decision making | 36 | $4,477 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,127 | $165 |
| Return visit (30+ min) | 23 | $2,265 | $84 |
2016: 8 services
| New patient visit (60+ min) | 78 | $13,428 | $172 |
| Critical care, first 30-74 minutes | 13 | $7,763 | $185 |
| Long return visit (40+ min) | 33 | $6,345 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,091 | $89 |
| Emergency department visit with high level of medical decision making | 20 | $2,661 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,640 | $165 |
| Return visit (30+ min) | 17 | $2,127 | $97 |
| Short return visit (20+ min) | 23 | $1,486 | $57 |
2015: 9 services
| New patient visit (60+ min) | 54 | $9,229 | $171 |
| Emergency department visit with high level of medical decision making | 39 | $5,724 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,677 | $92 |
| Critical care, first 30-74 minutes | 16 | $4,357 | $182 |
| Long return visit (40+ min) | 21 | $3,462 | $124 |
| Return visit (30+ min) | 30 | $3,441 | $96 |
| Short return visit (20+ min) | 27 | $2,042 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,958 | $178 |
| Short return visit | 12 | $372 | $31 |
2014: 7 services
| New patient visit (60+ min) | 45 | $8,363 | $186 |
| Return visit (30+ min) | 42 | $4,581 | $93 |
| Emergency department visit with high level of medical decision making | 19 | $2,812 | $148 |
| New patient visit (45+ min) | 15 | $2,277 | $152 |
| Short return visit (20+ min) | 22 | $1,703 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,664 | $92 |
| Short return visit | 11 | $540 | $42 |
2013: 6 services
| Return visit (30+ min) | 51 | $8,510 | $96 |
| New patient visit (60+ min) | 42 | $7,775 | $185 |
| Emergency department visit with high level of medical decision making | 30 | $4,484 | $140 |
| New patient visit (45+ min) | 22 | $3,229 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,170 | $87 |
| Long return visit (40+ min) | 12 | $2,119 | $132 |
Drugs they prescribed that Part D paid
$172,209
Pharmacies billed $172,209 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 458) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
405 generic and 53 brand-name prescriptions · $172,209 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Copaxone | None | 14 | $80,338 | $5,738 |
| Glatiramer Acetate | None | 12 | $20,019 | $1,668 |
| Qulipta | None | 14 | $17,889 | $1,278 |
| Aimovig | Migraine | 12 | $15,563 | $1,297 |
| Memantine Hcl Er | None | 15 | $3,224 | $215 |
See all 16 drugs
| Copaxone | None | 14 | $80,338 | $5,738 |
| Glatiramer Acetate | None | 12 | $20,019 | $1,668 |
| Qulipta | None | 14 | $17,889 | $1,278 |
| Aimovig | Migraine | 12 | $15,563 | $1,297 |
| Memantine Hcl Er | None | 15 | $3,224 | $215 |
| Lacosamide | None | 11 | $1,845 | $168 |
| Memantine | None | 35 | $1,567 | $45 |
| Levetiracetam | None | 47 | $1,248 | $27 |
| Quetiapine | None | 28 | $797 | $28 |
| Gabapentin | None | 37 | $756 | $20 |
| Donepezil | None | 35 | $733 | $21 |
| Carbidopa-Levodopa | None | 26 | $679 | $26 |
| Primidone | None | 15 | $257 | $17 |
| Clopidogrel | None | 13 | $225 | $17 |
| Ropinirole | None | 12 | $116 | $10 |
| Propranolol | None | 11 | $74 | $7 |
Year by year
| 2024 | 458 | 98 | 0% (0) | 12% | $172,209 |
| 2023 | 495 | 98 | 0% (0) | 9% | $156,914 |
| 2022 | 523 | 105 | 0% (0) | 8% | $181,903 |
| 2021 | 419 | 82 | 0% (0) | 10% | $86,418 |
| 2020 | 427 | 80 | 0% (0) | 13% | $106,041 |
| 2019 | 422 | 74 | 0% (0) | 13% | $106,517 |
| 2018 | 309 | 69 | 0% (0) | 11% | $57,575 |
| 2017 | 356 | 57 | 0% (0) | 12% | $39,811 |
| 2016 | 230 | 48 | 0% (0) | 8% | $22,069 |
| 2015 | 201 | 37 | 0% (0) | 7% | $19,397 |
| 2014 | 135 | 42 | 0% (0) | 21% | $19,381 |
| 2013 | 153 | 35 | 0% (0) | 19% | $13,129 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Copaxone | 12 | $75,584 | $6,299 |
| Glatiramer Acetate | 12 | $22,946 | $1,912 |
| Qulipta | 11 | $11,973 | $1,088 |
| Memantine | 54 | $3,188 | $59 |
| Sumatriptan | 14 | $3,101 | $222 |
| Levetiracetam | 54 | $1,647 | $31 |
| Carbidopa-Levodopa | 28 | $1,027 | $37 |
| Donepezil | 65 | $1,009 | $16 |
| Gabapentin | 36 | $819 | $23 |
| Quetiapine | 36 | $690 | $19 |
| Topiramate | 14 | $500 | $36 |
| Propranolol | 18 | $200 | $11 |
2022: 10 drugs
| Copaxone | 13 | $81,888 | $6,299 |
| Glatiramer Acetate | 11 | $20,744 | $1,886 |
| Quetiapine | 56 | $2,159 | $39 |
| Memantine | 47 | $1,872 | $40 |
| Levetiracetam | 60 | $1,839 | $31 |
| Donepezil | 74 | $1,352 | $18 |
| Gabapentin | 44 | $1,344 | $31 |
| Phenytoin Sodium Extended | 12 | $808 | $67 |
| Carbidopa-Levodopa | 23 | $793 | $34 |
| Escitalopram | 11 | $204 | $19 |
2021: 12 drugs
| Nuplazid | Parkinson's psychosis | 12 | $48,542 | $4,045 |
| Exelon | None | 12 | $8,696 | $725 |
| Rivastigmine | None | 15 | $3,295 | $220 |
| Memantine | None | 49 | $2,062 | $42 |
| Levetiracetam | None | 29 | $1,579 | $54 |
| Gabapentin | None | 35 | $1,376 | $39 |
| Phenytoin Sodium Extended | None | 14 | $1,302 | $93 |
| Carbidopa-Levodopa | None | 20 | $1,034 | $52 |
| Sumatriptan | None | 19 | $1,033 | $54 |
| Donepezil | None | 45 | $836 | $19 |
| Quetiapine | None | 33 | $351 | $11 |
| Topiramate | None | 14 | $235 | $17 |
2020: 11 drugs
| Nuplazid | Parkinson's psychosis | 12 | $42,466 | $3,539 |
| Exelon | None | 12 | $8,500 | $708 |
| Sumatriptan | None | 22 | $1,863 | $85 |
| Memantine | None | 54 | $1,841 | $34 |
| Levetiracetam | None | 26 | $1,171 | $45 |
| Donepezil | None | 50 | $846 | $17 |
| Lamotrigine | None | 16 | $835 | $52 |
| Carbidopa-Levodopa Er | None | 11 | $773 | $70 |
| Gabapentin | None | 33 | $705 | $21 |
| Carbidopa-Levodopa | None | 23 | $638 | $28 |
| Quetiapine | None | 28 | $294 | $10 |
2019: 12 drugs
| Nuplazid | Parkinson's psychosis | 12 | $37,879 | $3,157 |
| Exelon | None | 11 | $7,611 | $692 |
| Sumatriptan | None | 18 | $1,997 | $111 |
| Memantine | None | 28 | $1,910 | $68 |
| Levetiracetam | None | 30 | $1,136 | $38 |
| Lamotrigine | None | 34 | $891 | $26 |
| Donepezil | None | 37 | $779 | $21 |
| Gabapentin | None | 22 | $596 | $27 |
| Carbidopa-Levodopa | None | 21 | $502 | $24 |
| Quetiapine | None | 29 | $374 | $13 |
| Ropinirole | None | 16 | $367 | $23 |
| Topiramate | None | 11 | $190 | $17 |
2018: 10 drugs
| Sumatriptan | 19 | $3,606 | $190 |
| Levetiracetam | 37 | $1,612 | $44 |
| Lamotrigine | 19 | $740 | $39 |
| Ropinirole | 16 | $737 | $46 |
| Gabapentin | 25 | $494 | $20 |
| Quetiapine | 28 | $421 | $15 |
| Carbidopa-Levodopa | 15 | $364 | $24 |
| Propranolol | 12 | $161 | $13 |
| Donepezil | 18 | $153 | $8 |
| Topiramate | 11 | $121 | $11 |
2017: 11 drugs
| Sumatriptan | 24 | $5,779 | $241 |
| Levetiracetam | 30 | $1,557 | $52 |
| Carbidopa-Levodopa | 26 | $1,211 | $47 |
| Memantine | 13 | $1,099 | $85 |
| Lamotrigine | 17 | $552 | $32 |
| Quetiapine | 34 | $546 | $16 |
| Gabapentin | 22 | $390 | $18 |
| Escitalopram | 25 | $345 | $14 |
| Propranolol | 19 | $274 | $14 |
| Donepezil | 18 | $254 | $14 |
| Topiramate | 11 | $95 | $9 |
2016: 7 drugs
| Donepezil | 19 | $2,459 | $129 |
| Carbidopa-Levodopa Er | 23 | $1,831 | $80 |
| Levetiracetam | 13 | $859 | $66 |
| Carbidopa-Levodopa | 22 | $573 | $26 |
| Gabapentin | 22 | $357 | $16 |
| Quetiapine | 15 | $264 | $18 |
| Escitalopram | 12 | $121 | $10 |
2015: 5 drugs
| Donepezil | 21 | $3,130 | $149 |
| Carbidopa-Levodopa Er | 24 | $1,167 | $49 |
| Carbidopa-Levodopa | 17 | $453 | $27 |
| Gabapentin | 27 | $315 | $12 |
| Sumatriptan | 14 | $127 | $9 |
2014: 3 drugs
| Namenda | 19 | $8,523 | $449 |
| Donepezil | 29 | $2,821 | $97 |
| Gabapentin | 26 | $348 | $13 |
2013: 4 drugs
| Namenda | 20 | $6,411 | $321 |
| Carbidopa-Levodopa | 13 | $669 | $51 |
| Gabapentin | 40 | $560 | $14 |
| Donepezil | 31 | $539 | $17 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 2 | 2 | None | $159 |
| 2023 | 4 | 4 | None | $358 |
| 2022 | 2 | 4 | None | $158 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 5 | 9 | None | $743 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ceribell | Pocket Eeg Device | $125 | 1 payment
|
See the published payment
| Ceribell | Meals · 2025-05-07 | Pocket Eeg Device | $125 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $159
| Harrow Eye | None | $132 | 1 payment
|
| Argenx US | Vyvgart Hytrulo | $28 | 1 payment
|
2023: $358
| Horizon Therapeutics plc | Uplizna | $125 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $112 | 1 payment
|
| Biogen | Vumerity | $99 | 1 payment
|
| Pfizer | Paxlovid | $23 | 1 payment
|
2022: $158
| Alexion Pharmaceuticals | Soliris | $137 | 2 payments
|
| Abbvie | Qulipta | $22 | 1 payment
|
2020: $21
| Eisai | Fycompa | $21 | 1 payment
|
2019: $743
| Novartis Pharmaceuticals | Mayzent | $226 | 2 payments
|
| Eisai | Fycompa | $170 | 4 payments
|
| Stryker | Trevo | $140 | 1 payment
|
| Genentech USA | Ocrevus | $125 | 1 payment
|
| US WorldMeds | Apokyn | $83 | 1 payment
|
Professional record
- NPI
- 1659360139
- Licence
- CA 2OA8045
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00AX80450
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 777 Knowles Dr Ste 10, Los Gatos, CA, 95032
- NPI first listed
- 2005-10-18
- NPI last updated
- 2012-04-06
This is when the NPI record was last certified, not a medical board exam.